Kronos Bio
Patents, Design & Utilities

Last updated:

List of all Kronos Bio patents 7 in total

Status Patent
Grant
Utility: Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyraz- in-8-amine bisemsylate as Syk inhibitors External link
Filling date: 26 Sep 2025 Issue date: 12 Jul 2022
Grant
Utility: Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidaz- o[1,2-a]pyrazin-8-amine as Syk inhibitors External link
Filling date: 26 Sep 2025 Issue date: 24 May 2022
Application
Utility: COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CDK9 ACTIVITY External link
Filling date: 26 Sep 2025 Issue date: 6 Jan 2022
Grant
Utility: Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity External link
Filling date: 26 Sep 2025 Issue date: 26 Oct 2021
Application
Utility: CRYSTALLINE MONOMESYLATE SALT OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZ- O[1,2-a]PYRAZIN-8-AMINE External link
Filling date: 26 Sep 2025 Issue date: 4 Mar 2021
Grant
Utility: Imidazopyridines Syk inhibitors External link
Filling date: 26 Sep 2025 Issue date: 24 Nov 2020
Application
Utility: Compounds, Compositions, and Methods for Modulating CDK9 Activity External link
Filling date: 26 Sep 2025 Issue date: 30 Apr 2020

Showing 1 to 7 of 7 patents.